BIRAC Invites Research Proposals in the Areas of Vaccines, Biotherapeutics

The Biotechnology Industry Research Assistance Council(BIRAC) has invited research proposals from biotech companies in the areas of vaccines, biotherapeutics, medical devices & diagnostics under the National Biopharma Mission, which is an industry-academia collaborative mission for accelerating discovery research to early development for biopharmaceuticals named Innovate in India (I3). I3 is a mission of Department of Biotechnology (DBT) in collaboration with World Bank which will be implemented by BIRAC .

In the area of vaccine, the focus of this program will be on support for accelerating development of novel vaccine candidates for HPV, dengue and pneumococcal; and novel and complex vaccine candidates for other diseases of high burden and priority in India. In the area of biotherapeutics, the thrust will be on support for development of biosimilars (therapeutic proteins and monoclonal antibodies) for cancer, rheumatoid arthritis and diabetes. Besides, the program will focus on support for establishment of process development laboratory, CMC facility, GLP validation facility and cell line repository. In the areas of medical devices & diagnostics, the focus of this programme will be on support for accelerating development of critical medical device technologies for relevant product segments, and core technologies as platform technologies for priority products.

The aim of the mission is to enable and nurture an ecosystem for preparing India's technological and product development capabilities in biopharmaceutical to a level that will be globally competitive over the next decade, and transform the health standards of India's population through affordable product development. The program will specifically focus on the development of new vaccines, bio-therapeutics, diagnostics and medical devices to address the rising burden of diseases in the country.